Sort
78,016 grants matching “breast cancer”
Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer
$1,001,029Yicheng Wang · Immunova Therapeutics, Llc · R44 · FY2024 · CA
Plant-based diets and risk of cancer
$1,000,819Gary E. Fraser · Loma Linda University · U01 · FY2013 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$1,000,669Irving Lerner Weissman · Stanford University · R35 · FY2023 · CA
Management of Mucositis with GM-CSF
$1,000,662Marylin J Dodd · University Of California, San Francisco · R01 · FY2007 · CA
Howard/Hopkins Cancer Centers Partnership
$1,000,564William George Nelson · Johns Hopkins University · U54 · FY2008 · CA
TARGETING PROLIFERATIVE AND DRUG RESISTANCE PATHWAYS IN TRIPLE-NEGATIVE BREAST CANCER STEM CELLS
$1,000,434Icahn School Of Medicine At Mount Sinai · · FY2017 · Department of the Army
ARTIFICIAL INTELLIGENCE-BASED DIFFRACTION ANALYSIS (AIDA) FOR POINT-OF-CARE BREAST CANCER CLASSIFICATION
$1,000,126The General Hospital Corporation · · FY2019 · Department of the Army
Statistical Coordinating Center for the Breast Cancer Surveillance Consortium
$1,000,072Diana L Miglioretti · Kaiser Foundation Health Plan Of Washington · U01 · FY2006 · CA
Development of Breast Cancer Risk Model for the Pacific
$1,000,018Robert A Underwood · University Of Guam · U54 · FY2009 · CA
Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets
$1,000,001Hongkang Zhang · Quiver Bioscience Inc. · R44 · FY2021 · CA
Development of a Companion Diagnostic Assay for Detection of ADAM8-Positive Cancers
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2022 · CA
SIRPant Technology for anti-Cancer Immunity
$1,000,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2023 · CA
Molecular breast imaging to guide early-stage patient care
$1,000,000Douglas J. Wagenaar · Gamma Medica-Ideas, Inc. · R44 · FY2009 · CA
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America
$1,000,000Rafael Guerrero-Preston · Lifegene-Biomarks, Inc. · R44 · FY2023 · CA
Establishment of Molecular Biomedical Imaging Laboratory
$1,000,000David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2009 · EB
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2018 · CA
Scaling Social Determinants of Health Screening, Social Support and Anti-Racism Training to Reduce Inequities in Minority Cancer Survivor Health and Wellbeing in Washington, DC
$1,000,000Hannah Arem · Medstar Health Research Institute · U01 · FY2023 · DP
SBIR Phase II: Antibody-Drug Conjugates (ADCs) with High Drug-Antibody Ratios (DAR) and Molecularly Targeted Payloads
$1,000,000Yivan Jiang · Window Therapeutics, Inc. · · FY2025 · TIP
Programming Metabolically Fit TILs for Immunotherapy
$1,000,000Shikhar Mehrotra · Lipo-Immuno Tech, Llc · R42 · FY2023 · CA
DCTD Cancer Diagnosis
$1,000,000Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
SBIR Phase II: Non-planar Spectral Breast Computed Tomography (CT)
$1,000,000Peymon Ghazi · Malcova Inc · · FY2023 · TIP
Precisely Shaped Acoustic Ablation of Tumors Under 3D Ultrasound Image Guidance
$1,000,000Everette C Burdette · Acoustic Medsystems, Inc. · R44 · FY2009 · CA
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
$1,000,000Laurel A. Schaider · Silent Spring Institute · U01 · FY2021 · TS
Programming Metabolically Fit TILs for Immunotherapy
$1,000,000Shikhar Mehrotra · Lipo-Immuno Tech, Llc · R42 · FY2024 · CA
Portable Imaging Device for Prostate Cancer Detection
$1,000,000Armen Sarvazyan · Artann Laboratories, Inc. · R44 · FY2008 · CA